Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Pia Osterlund"'
Autor:
Philip Falk, Mira Severin, Åke Berglund, Marianne G. Guren, Eva Hofsli, Pia Österlund, Anne Tandberg, Jakob Eberhard, Halfdan Sorbye
Publikováno v:
Cancer Treatment and Research Communications, Vol 31, Iss , Pp 100517- (2022)
Background: The incidence of colorectal cancer (CRC) in individuals of fertile age is increasing. Oxaliplatin is a cornerstone treatment in the adjuvant setting for stage III and high-risk stage II CRC. Limited data exist on possible side effects of
Externí odkaz:
https://doaj.org/article/3e6fb0374fb14640929b1684072c3445
Autor:
Richard A. Forsgård, Vannina G Marrachelli, Jere Lindén, Rafael Frias, Maria Carmen Collado, Riitta Korpela, Daniel Monleon, Thomas Spillmann, Pia Österlund
Publikováno v:
Translational Oncology, Vol 12, Iss 8, Pp 1122-1130 (2019)
Gastrointestinal toxicity is a frequently observed adverse event during cancer treatment with traditional chemotherapeutics. Currently, traditional chemotherapeutics are often combined with targeted biologic agents. These biologics, however, possess
Externí odkaz:
https://doaj.org/article/00d502f4dbe745d68aa4ec0ab7141ecd
Autor:
Stine Braendegaard Winther, Pia Österlund, Åke Berglund, Bengt Glimelius, Camilla Qvortrup, Halfdan Sorbye, Per Pfeiffer, on behalf of the Academy of Geriatric Cancer Research (AgeCare)
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-7 (2017)
Abstract Background Metastatic colorectal cancer (mCRC) is a disease of older age, but there is a relative lack of knowledge about effects of chemotherapy in older patients as they are under-represented in clinical trials. Little data can guide wheth
Externí odkaz:
https://doaj.org/article/99c67e463c064c20bf3675724a4d4f49
Publikováno v:
Frontiers in Nutrition, Vol 6 (2019)
Background: Locally advanced head and neck cancer is managed either by combined surgery and (chemo) radiotherapy or definitive (chemo) radiotherapy, which may deteriorate nutritional status. Previous data have shown that intensive nutritional interve
Externí odkaz:
https://doaj.org/article/c82e4e97e59246ca83d52886bd3cd572
Autor:
Abir Salwa Ali, Malin Grönberg, Birgitte Federspiel, Jean-Yves Scoazec, Geir Olav Hjortland, Henning Grønbæk, Morten Ladekarl, Seppo W Langer, Staffan Welin, Lene Weber Vestermark, Johanna Arola, Pia Österlund, Ulrich Knigge, Halfdan Sorbye, Lars Grimelius, Eva Tiensuu Janson
Publikováno v:
PLoS ONE, Vol 12, Iss 11, p e0187667 (2017)
Gastroenteropancreatic neuroendocrine carcinomas (GEP-NECs) are aggressive, rapidly proliferating tumors. Therapeutic response to current chemotherapy regimens is usually short lasting. The aim of this study was to examine the expression and potentia
Externí odkaz:
https://doaj.org/article/5285c1eba0e445af90c623f9710a9b5f
Autor:
Annika Ålgars, Tuulia Avoranta, Pia Österlund, Minnamaija Lintunen, Jari Sundström, Terhi Jokilehto, Ari Ristimäki, Raija Ristamäki, Olli Carpén
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e99590 (2014)
Anti-EGFR therapy is commonly used to treat colorectal cancer (CRC), although only a subset of patients benefit from the treatment. While KRAS mutation predicts non-responsiveness, positive predictive markers are not in clinical practice. We previous
Externí odkaz:
https://doaj.org/article/7f03e5ca70bd491b976543bf3a340335
Autor:
Helena Kristiina Orell, Anne Katariina Pohju, Pia Osterlund, Ursula Sonja Schwab, Paula Ravasco, Antti Mäkitie
Publikováno v:
Frontiers in Nutrition, Vol 9 (2022)
AimThis study aimed to determine the prevalence of malnutrition in a head and neck cancer (HNC) population according to the Global Leadership Initiative on Malnutrition (GLIM) criteria and to assess its relation to survival. The secondary aim was to
Externí odkaz:
https://doaj.org/article/0370ce0395274573a1aa4ee4ebb1c3f0
Autor:
Emerik Osterlund, Ari Ristimäki, Soili Kytölä, Teijo Kuopio, Eetu Heervä, Timo Muhonen, Päivi Halonen, Raija Kallio, Leena-Maija Soveri, Jari Sundström, Mauri Keinänen, Annika Ålgars, Raija Ristamäki, Halfdan Sorbye, Per Pfeiffer, Luís Nunes, Tapio Salminen, Annamarja Lamminmäki, Markus J. Mäkinen, Tobias Sjöblom, Helena Isoniemi, Bengt Glimelius, Pia Osterlund
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundKRAS mutations, present in over 40% of metastatic colorectal cancer (mCRC), are negative predictive factors for anti-EGFR therapy. Mutations in KRAS-G12C have a cysteine residue for which drugs have been developed. Published data on this sp
Externí odkaz:
https://doaj.org/article/decb120b6a4a470ea68f4e7d8f7c7d6d
Autor:
Pia Osterlund, Helena Isoniemi
Publikováno v:
The Lancet Regional Health. Europe, Vol 5, Iss , Pp 100135- (2021)
Externí odkaz:
https://doaj.org/article/fc94584cd56742789ad3fe2a20893cc0
Autor:
Pia Osterlund, Tapio Salminen, MD, Leena-Maija Soveri, MD, Raija Kallio, MD, Ilmo Kellokumpu, MD, Annamarja Lamminmäki, MD, Päivi Halonen, MD, Raija Ristamäki, MD, Eila Lantto, MD, Aki Uutela, MD, Emerik Osterlund, MD, Ali Ovissi, MD, Arno Nordin, MD, Eetu Heervä, MD, Kaisa Lehtomäki, MD, Jari Räsänen, MD, Maija Murashev, MD, Laura Aroviita, MD, Antti Jekunen, Prof, Reneé Lindvall-Andersson, MD, Paul Nyandoto, MD, Juha Kononen, MD, Anna Lepistö, MD, Tuija Poussa, MSc, Timo Muhonen, MD, Annika Ålgars, MD, Helena Isoniemi, Prof
Publikováno v:
The Lancet Regional Health. Europe, Vol 3, Iss , Pp 100049- (2021)
Background: Resection of colorectal cancer (CRC) metastases provides good survival but is probably underused in real-world practice. Methods: A prospective Finnish nationwide study enrolled treatable metastatic CRC patients. The intervention was the
Externí odkaz:
https://doaj.org/article/242b5d11ce0240999caa17287c9963a7